Cargando…
Ketanserin as potential additive drug to improve V/Q mismatch in COVID-19?
Autores principales: | Kuindersma, M., Spronk, P. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453366/ https://www.ncbi.nlm.nih.gov/pubmed/32859243 http://dx.doi.org/10.1186/s13054-020-03257-y |
Ejemplares similares
-
Effects of ketanserin on experimental colitis in mice and macrophage function
por: XIAO, JUNHUA, et al.
Publicado: (2016) -
Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans
por: Maqueda, Ana Elda, et al.
Publicado: (2016) -
Ketanserin and Naftopidil Enhance the Potentiating Effect of Alpha-Methyl-Serotonin on the Neurally-Induced Contraction of Human Isolated Urinary Bladder Muscle Strips
por: Hattori, Tsuyoshi, et al.
Publicado: (2017) -
Effect of combination of ketanserin and escitalopram on behavioral anomalies after olfactory bulbectomy: Prediction of quick onset of antidepressant action
por: Pandey, Dilip K., et al.
Publicado: (2014) -
Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants
por: Becker, Anna M, et al.
Publicado: (2022)